Billionaire Profile
Julian Baker
Global Rank
#1239

Image: J. Alden Weir | Public domain | via Wikimedia Commons

Julian Baker

CEO, Biotech investing
UNITED STATES
Real-Time Net Worth
$3.393B
Estimated based on Biotech investing stock value as of March 6, 2026
0% (24h)
Age
59
Source
Biotech investing
Industry
Finance & Investments
Citizenship
UNITED STATES

Biography

Julian Baker is a prominent figure in the world of biotech investing. He is the Managing Partner of Baker Bros. Advisors LP, a firm that focuses on long-term investments in publicly traded life-sciences companies. Baker, along with his brother Felix, founded the firm in 2000. He has an estimated net worth of $2.6 billion as of late 2025. He holds several leadership positions, including Chairman of Incyte Corp and Director of Acadia Pharmaceuticals. Baker's career in fund management began in 1994 with a biotechnology investing partnership with the Tisch family. He holds an A.B. Magna Cum Laude from Harvard University.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life and Education

Julian Baker's journey began with a solid foundation in education. He earned an A.B. Magna Cum Laude from Harvard University.

Rise to Success

Baker's career in finance began in 1988 at the private equity investment arm of Credit Suisse First Boston Corporation. In 1994, Baker co-founded a biotechnology investing partnership with the Tisch family. Baker and his brother, Felix, then founded Baker Bros. Advisors in 2000, which manages nearly $22 billion, all invested in biotech stocks.

Key Business Strategies

Baker Bros. Advisors employs a long-term investment strategy, focusing on publicly traded life sciences companies. Their approach involves taking large, concentrated positions in companies with significant value creation potential.

Philanthropy

Specific details on Julian Baker's philanthropic endeavors could not be found with the available search results.

Career Milestones

1988

Began Career at Credit Suisse First Boston

Worked in the private equity investment arm of Credit Suisse First Boston Corporation.

1994

Co-founded Biotech Investing Partnership

Co-founded a biotechnology investing partnership with the Tisch family.

2000

Founded Baker Bros. Advisors

Founded Baker Bros. Advisors with his brother, Felix Baker.

2015

Director at Acadia Pharmaceuticals, Inc.

Began serving as Director at Acadia Pharmaceuticals, Inc..

2025

Chairman at Incyte Corp

Began serving as Chairman at Incyte Corp.

Philanthropy & Social Impact

Unknown

Unknown

Undisclosed

Philanthropic information not found

Business Philosophy & Leadership

Notable Quotes

"Quote not available"

Leadership Principles

Long-Term Investing

Focuses on long-term investments in life sciences companies with the potential for significant value creation.

Controversies & Challenges

Unknown

Unknown

Controversies not found.